4//SEC Filing
CHALMERS DEREK T 4
Accession 0001209191-21-024294
CIK 0001346830other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:46 PM ET
Size
7.7 KB
Accession
0001209191-21-024294
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Award
Common Stock
2021-03-30+52,000→ 1,002,511 total - Award
Employee Stock Option (Right to Buy)
2021-03-30+103,000→ 103,000 totalExercise: $20.59Exp: 2031-03-30→ Common Stock (103,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in three equal annual installments on each of March 30, 2022, March 30, 2023 and March 30, 2024, in each case, subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
- [F2]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 30, 2021, in each case subject to the Reporting Person's continued service as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001166287
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:46 PM ET
- Size
- 7.7 KB